jueves, 10 de septiembre de 2020

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Daily Recap

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

By ADAM FEUERSTEIN


WIN MCNAMEE/GETTY IMAGES
AstraZeneca's CEO said in a private call with investors that the participant had symptoms consistent with a rare spinal inflammatory disorder.

No hay comentarios: